
The three major A-share indices rose collectively, with a significant increase in the biopharmaceutical sector. CPO continues to squeeze shorts, while Hong Kong stocks fluctuated and fell, tech stocks retreated, and government bonds and commodities declined

I'm PortAI, I can summarize articles.
The A-share innovative drug sector saw a short-term surge, with Kanion Pharmaceutical hitting the daily limit, and Gan & Lee, NuoSiLanDe, Xintian Pharma, and others rising significantly. The CPO concept continues to squeeze shorts, with Zhongji Xuchuang rising over 4%, and its total market value surpassing 300 billion yuan for the first time; Cambridge Technology has achieved three consecutive limit-ups in five days, and Dekeli has risen over 10%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

